Pharmaceutical Companies Intellectual Property and Research Paper

Download this Research Paper in word format (.doc)

Note: Sample below may appear distorted but all corresponding word document files contain proper formatting

Excerpt from Research Paper:

As a result, this protection was removed to increase the supply and ensure that the public has access to affordable drugs. ("Pharmaceutical Companies," n.d., pp. 97-99)

Some of the negative implications of this decision are that there could be large amounts of generic drugs produced. This is because the various protections were removed to the point, that a number of players could begin manufacturing the medication. Over the course of time, this could destroy any kind of financial incentive in these areas. Once this occurs, it means that any kind of profit motives for these firms to sell drugs in these areas will decrease. This is when the available supply could decline, because there is too much competition. ("Pharmaceutical Companies," n.d., pp. 97-99)

At the same time, the quality of products could be inferior. This is because many firms will have select procedures in place to ensure that everyone is receiving the right dosage. The problem is that some companies could reduce this amount. Once this takes place, it means that these drugs will not be as effective in helping to treat those who are suffering from HIV / AIDS. Once this occurs, is when larger segments of the poor and middle class could begin to see higher mortality rates from the disease. ("Pharmaceutical Companies," n.d., pp. 97-99)

The way that this could impact other industries is to remove protections they enjoy for particular products. Where, their underling costs will increase for related materials such as bottles and plastic bags. This is because the medication is being distributed to larger segments of the population. Once this occurs, it means that various industries could be dealing with possible inflation issues down the road. This is the point that other industries will have trouble keeping up with these rising costs (which they are passing onto consumers). ("Pharmaceutical Companies," n.d., pp. 97-99)

Given the initiatives announced by global development and aid organizations and among pharmaceutical companies themselves, was it necessary to relax IPR rules in order to ensure that adequate supplies of AIDs medications would be available for distribution in the developing world?

Yes, the reason why the various rules had to be relaxed was to ensure that everyone had access to these drugs when they need them. If they kept the current procedures in place, this would have limited the sale of HIV / AIDS medication to the affluent inside various developing nations. This would have caused uneven amounts of economic growth, which would have an adverse impact on any kind of economic development. This is because large segments of the population have higher mortality rates. Over the course of time, this will create a situation where there will be issues of declining productivity and a loss in the wealth of these regions. ("Pharmaceutical Companies," n.d., pp. 94-103)

As a result, once there was some kind change in regulations is when drug manufactures were able to supply developing countries with larger quantities. This is the point they increased their market share in these areas. While at the same time, they addressed the lingering public health issues that were facing many of these nations. Once this occurred, is when there would be an increase in the total amounts of supplies that were available in these regions. This is when the mortality rates associated with the disease began to stabilize and then decrease. ("Pharmaceutical Companies," n.d., pp. 94-103)

What role do MNCs have in providing funding or other assistance to international organizations such as the Global Fund?

The way that MNC's are providing funding to international organizations is to establish for profit entities that will distribute HIV / AIDS drugs to these areas. The way that this works, is these various nonprofits, corporations and governments can make contributions to this fund. They will provide assistance to developing nations in offering the public these drugs for lower costs or free. Once this occurs, it means that they are addressing the epidemic by providing the public with a way to ensure that these areas receive the medication they need. This is when the manufactures will be able to maintain their profit margins. While at the same time, it is providing developing nations with a vital supply of drugs for large segments of the population. ("Pharmaceutical Companies," n.d., pp. 94-103)

Clearly, the HIV / AIDS crisis is creating shifts in the way that drug companies are looking at issues such as patent protections. This is because the standard rules of the past, are offering them with a way of maximizing their profits. However, it is also effectively helping select segments of these populations. Once this occurs, is when the mortality rate in these areas will increase exponentially. This is the point that economic growth in these regions could reverse. To deal with these lingering issues, the regulations on patent protections were loosened to increase the available supply to consumers. Over the course of time, this providing these areas with a large amount of drugs that are available to the general public. At the same time, it helped to keep the costs of the medication as low as possible. This is when most people could afford the treatment options that were available. Once this took place, it meant that total number of deaths began to decline consistently. As a result, the net impact of these efforts is that they helped to save millions of lives around the world.


Global Report. (2009). UNAIDS. Retrieved from:

Pharmaceutical Companies. (n.d.)., 94 -- 103.

Hunter, S. (2003). Black Death. New York, NY: McMillian

Poku, N. (2005). AIDS in Africa. Cambridge: Poulty.

Shinn, D. (2008). African Migration and the Brain Drain. Institute for African Studies. Retrieved…[continue]

Some Sources Used in Document:


Cite This Research Paper:

"Pharmaceutical Companies Intellectual Property And" (2011, November 19) Retrieved December 8, 2016, from

"Pharmaceutical Companies Intellectual Property And" 19 November 2011. Web.8 December. 2016. <>

"Pharmaceutical Companies Intellectual Property And", 19 November 2011, Accessed.8 December. 2016,

Other Documents Pertaining To This Topic

  • Pharmaceutical Companies Intellectual Property and the Global AIDS...

    Pharmaceutical Companies, Intellectual Property, and the Global AIDS Epidemic For this case study, six questions had been asked. The first one is: Should pharmaceutical companies distribute drugs at low cost in third world countries? What are the pros and cons of such an approach? The second one is: What are the principal arguments of pharma companies who oppose making exception to IPR laws for developing countries? What are the arguments by

  • Intellectual Property Rights Several Countries

    However, the rights have some confinements incorporating the limitations and other considerations of issues like their contradiction with the fundamental rights and the codified provisions in force. The legal issues involving intellectual property rights have two dimensions. Firstly, those that provide exclusive rights only in the sphere of copying / reproduction of the item or act safeguarded and secondly, those which provide a right to deter others from doing

  • Pharmaceutical Company Lions Gate Chief

    Managed a team of 50 people that includes 10 direct reports. Grew Wal-mart drugs portfolio profit by $14 Million (+26%) through driving volume growth and reconfiguration of packaging offerings that drove significant cost savings. Responsibilities and duties: Maintains full accountability for profit and loss and delivering volume and profit objectives. Spearheads both strategic and tactical initiatives that leads to growth of Liongate's new product. Reshapes marketing organization through effective recruiting,

  • Marketing Product Safety and Intellectual Property Legal

    Marketing Product Safety, And Intellectual Property Legal and Ethical Considerations in Marketing, Product Safety, and Intellectual Ethics and legal issues refer to the morals and principles that govern the behavior and conduct of individuals or organizations. These legal principles and ethics serve to guide and offer directions on how to act or respond when faced with moral dilemmas. Marketing, advertising and product safety are areas of importance to everyone in the community.

  • Case Study of Pharmaceutical Companies

    Management Case Analysis: Pharma, Intellectual Property Prior to 2003, the U.S. pharmaceutical industry heavily restricted intellectual property rights that would allow African countries and others ravaged by AIDS to receive generic medicine There are a great deal of shocking statistics regarding the global populations living with and dying from AIDS, particularly in the age group of 15 -- 19 Health is a factors that is considered relative to a country's wealth; in Africa, a

  • Wyeth Pharmaceuticals Company Respected Madam Sir

    (Drug Creation Process: Learn and Confirm, a new Paradigm for Clinical Development at Wyeth) Pharmaceuticals - a knowledge driven industry: Pharmaceuticals happen to be one of the most extremely 'Knowledge Driven' industries that is always in a state of change. Human, animal, and environmental health remains the topmost interest of the society. Diversities in life form and infections render grave challenges to the formulation of particular and targeted solutions. Drug discovery

  • China s Intellectual Property Rights Current Issues Strategic Considerations...

    China's Intellectual Property Rights: Current Issues, Strategic Considerations And Problem Solving In this paper, the focus is primarily on the Intellectual Property Rights (IPR) that are given to individuals within the Republic of China. The paper starts off by defining IPR and the different ways that IPR is provided like copyright infringement. The paper them moves on to define IPR and its progression in China through the imperialistic years, the era

Read Full Research Paper
Copyright 2016 . All Rights Reserved